Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

被引:1523
作者
Hidron, Alicia I. [2 ]
Edwards, Jonathan R. [1 ]
Patel, Jean [1 ]
Horan, Teresa C. [1 ]
Sievert, Dawn M. [1 ]
Pollock, Daniel A. [1 ]
Fridkin, Scott K. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA
[2] Emory Univ, Sch Med, Div Infect Dis, Dept Med, Atlanta, GA 30322 USA
关键词
D O I
10.1086/591861
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE. To describe the frequency of selected antimicrobial resistance patterns among pathogens causing device-associated and procedure-associated healthcare-associated infections (HAIs) reported by hospitals in the National Healthcare Safety Network (NHSN). METHODS. Data are included on HAIs (ie, central line-associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated pneumonia, and surgical site infections) reported to the Patient Safety Component of the NHSN between January 2006 and October 2007. The results of antimicrobial susceptibility testing of up to 3 pathogenic isolates per HAI by a hospital were evaluated to define antimicrobial-resistance in the pathogenic isolates. The pooled mean proportions of pathogenic isolates interpreted as resistant to selected antimicrobial agents were calculated by type of HAI and overall. The incidence rates of specific device-associated infections were calculated for selected antimicrobial-resistant pathogens according to type of patient care area; the variability in the reported rates is described. RESULTS. Overall, 463 hospitals reported 1 or more HAIs: 412 (89%) were general acute care hospitals, and 309 (67%) had 200-1,000 beds. There were 28,502 HAIs reported among 25,384 patients. The 10 most common pathogens (accounting for 84% of any HAIs) were coagulase-negative staphylococci (15%), Staphylococcus aureus ( 15%), Enterococcus species (12%), Candida species (11%), Escherichia coli (10%), Pseudomonas aeruginosa (8%), Klebsiella pneumoniae (6%), Enterobacter species (5%), Acinetobacter baumannii (3%), and Klebsiella oxytoca (2%). The pooled mean proportion of pathogenic isolates resistant to antimicrobial agents varied significantly across types of HAI for some pathogen-antimicrobial combinations. As many as 16% of all HAIs were associated with the following multidrug- resistant pathogens: methicillin-resistant S. aureus (8% of HAIs), vancomycin-resistant Enterococcus faecium (4%), carbapenem-resistant P. aeruginosa (2%), extended-spectrum cephalosporin-resistant K. pneumoniae (1%), extended-spectrum cephalosporin-resistant E. coli (0.5%), and carbapenem-resistant A. baumannii, K. pneumoniae, K. oxytoca, and E. coli (0.5%). Nationwide, the majority of units reported no HAIs due to these antimicrobial-resistant pathogens.
引用
收藏
页码:996 / 1011
页数:16
相关论文
共 28 条
  • [1] Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City
    Bradford, PA
    Bratu, S
    Urban, C
    Visalli, M
    Mariano, N
    Landman, D
    Rahal, JJ
    Brooks, S
    Cebular, S
    Quale, J
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (01) : 55 - 60
  • [2] Anti-infective research and development - problems, challenges, and solutions
    Bradley, John S.
    Guidos, Robert
    Baragona, Steve
    Bartlett, John G.
    Rubinstein, Ethan
    Zhanel, George G.
    Tino, Michael D.
    Pompliano, David L.
    Tally, Frank
    Tipirneni, Praveen
    Tillotson, Glenn S.
    Powers, John H.
    Tillotson, Glenn S.
    [J]. LANCET INFECTIOUS DISEASES, 2007, 7 (01) : 68 - 78
  • [3] National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
    Cardo, D
    Horan, T
    Andrus, M
    Dembinski, M
    Edwards, J
    Peavy, G
    Tolson, J
    Wagner, D
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) : 470 - 485
  • [4] CDC, NAT HEALTHC SAF NETW
  • [5] *CDC, NAT NOS INF SURV NNI
  • [6] Community-associated MRSA - Resistance and virulence converge
    Chambers, HF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14) : 1485 - 1487
  • [7] *CLSI, 2006, M39A2 CLSI
  • [8] *CLSI, 2008, M100S18 CLSI S
  • [9] Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program
    Deshpande, Lalitagauri M.
    Fritsche, Thomas R.
    Moet, Gary J.
    Biedenbach, Douglas J.
    Jones, Ronald N.
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 58 (02) : 163 - 170
  • [10] Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America
    Diekema, DJ
    Pfaller, MA
    Jones, RN
    Doern, GV
    Kugler, KC
    Beach, ML
    Sader, HS
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 13 (04) : 257 - 271